CHU de Saint-Etienne
Saint-Etienne, 42055, France
Location contact
Bogdan GALUSCA, MD PhD
SUB_INVESTIGATOR
Fabien SCHNEIDER, MD
CONTACT
(0)477127529 ext. +33
Natacha GERMAIN, MD PhD
SUB_INVESTIGATOR
NCT Number: NCT07344831
Lipid restriction is significant in anorexia nervosa and limits therapeutic management. The multisensory perception of fat is altered, creating an aversion to lipids. The investigators aim to characterize the impact of sensory stimulation (smells or images) associated with specific tastes using neuropsychological assessments and functional MRI. Some volatile aromas can enhance the perception of the associated taste. The investigators hypothesize that such associations are altered in anorexia nervosa for fatty foods but may be preserved for sweet tastes, and that this alteration contributes to the maintenance of the disease. The interdependence of different sensory perceptions of lipids could play a major role in the therapeutic approach, aiding in the deconditioning of this aversion and the restoration of positive food sensory associations.
Trial opening soon.
Get Notified18 year and older
Female
Interventional
Not applicable
Saint-Etienne, 42055, France
Bogdan GALUSCA, MD PhD
SUB_INVESTIGATOR
Fabien SCHNEIDER, MD
CONTACT
(0)477127529 ext. +33
Natacha GERMAIN, MD PhD
SUB_INVESTIGATOR
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
One hour MRI examination
one hour sensory testings
Time frame: Day 1
Estimation of the "fatty vs. neutral" contrast when all three senses are used, comparing AN patients to the normal-weight control group (NC group) in each voxel of the brain volume (whole-brain analysis) and in the orbitofrontal cortex (ROI analysis).
Time frame: Day 1
Estimation of the "fatty vs. neutral" contrast when all three senses are used, comparing AN patients to the control group with a similar BMI (CT group) in each voxel of the brain volume (whole-brain analysis) and in the orbitofrontal cortex (ROI analysis).
Time frame: Day 1
BOLD signal variations between the groups (AN, NC, and CT) for the "sweet vs. neutral" contrast.
Time frame: Day 1
BOLD signal variations for single vs. three senses simultaneously for each group and between groups for the "fatty vs. neutral" and "sweet vs. neutral" contrasts.
Time frame: DAY 1.
Body Mass Index
Time frame: Day 1
MediSens tests of olfactory and gustatory abilities
Time frame: Day 1
Brain morphometric measures and voxel-based morphometry.
Contact information is provided by the study sponsor or research team.
Fabien SCHNEIDER, MD
CONTACT
(0)477127529 ext. +33
Florence RANCON, CDP
CONTACT
(0)477829458 ext. +33
Centre Hospitalier Universitaire de Saint Etienne
Other
Acronym: ANOVERSION
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07726524
Anorexia Nervosa, Anorexia Nervosa Restricting Type
San Francisco, California, United States
View Trial DetailsNCT07692945
Anorexia Nervosa, Feeding and Eating Disorders
Chicago, Illinois, United States
View Trial DetailsNCT07350720
Anorexia Nervosa, Eating Disorders
View Trial DetailsNCT07644728
Anorexia Nervosa, Behavior
View Trial Details